The Sachs and Braun labs at the University of Minnesota bring together molecular engineering, quantitative biosensors, and cellular models to understand how proteins and signaling pathways contribute to neurodegeneration and inflammation.
Led by Jonathan Sachs and Anthony Braun, our collaborating research groups develop tools to measure biological processes in living cells and use those measurements to discover and evaluate potential therapeutic strategies.
Our Research
Protein Assembly & Neurodegeneration
Proteins such as α-synuclein, tau, and TDP-43 can adopt different conformations and assemble into distinct molecular states. We develop live-cell approaches to measure these changes and study how they relate to cellular function. This work connects molecular biophysics with disease models and compound screening, and gives trainees the chance to investigate how disease-associated proteins behave inside cells.
Inflammation & Cell Signaling
We study how receptors organize and signal at the cell surface, with a focus on TNFR1 and TNFR2. Our research has used fluorescence-based assays to examine receptor conformational changes and identify small molecules that modulate TNFR1 signaling. We have also developed Affibody protein binders that selectively antagonize TNFR1 while preserving TNFR2 function, and studied ways to improve their stability. Trainees can work across receptor biology, biosensor measurements, protein engineering, and functional assays.
Biosensors & High-Throughput Screening
We engineer fluorescence lifetime FRET (FLT-FRET) biosensors to measure protein interactions and conformational changes in living cells. Because FLT-FRET measures the donor’s fluorescence decay time rather than relying only on emission intensity, it can provide more precise measurements and reveal changes that may be difficult to distinguish with intensity-based FRET. We have applied these biosensors in pilot screens of approximately 3,000 compounds, including FDA-approved drug-repurposing collections, and in larger screens of 50,000 compounds. Trainees can contribute to biosensor design, assay optimization, screening, and follow-up validation.
Therapeutic Discovery & Cellular Models
We combine biosensor screens with complementary assays to determine whether candidate compounds alter a target process and produce meaningful effects in cells. Our work includes developing high-content imaging assays alongside molecular readouts, helping connect biosensor measurements to cellular phenotypes. Trainees can help build and refine assays, compare screening results across methods, and investigate promising compounds in cellular models.
Our Labs
Two collaborating laboratories in the University of Minnesota Department of Biomedical Engineering, combining complementary expertise in molecular therapeutics.
Jonathan N. Sachs, PhD
Professor and Department Head
Principal Investigator, Sachs Lab
Molecular mechanisms of disease and therapeutic strategies targeting protein interactions and cellular signaling in neurodegneration and inflammation.
Anthony R. Braun, PhD
Research Assistant Professor
Principal Investigator, Braun Lab
Fluorescent biosensor engineering, multiplexed measurements, and therapeutic discovery in models of neurodegeneration.
Publications
Explore our published work on protein assembly, receptor signaling, biosensors, and therapeutic discovery.
Join Our Research Community
Interested in our research? Prospective trainees and collaborators are welcome to contact us to discuss research interests and potential opportunities.